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1. Introduction  
Characteristic symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) have been 
recognized in the medical literature for over 200 years. The earliest known clinical 
description is found in the book by the Scottish physician Sir Alexander Crichton, entitled 
An Inquiry into the Nature and Origins of Mental Derangement (Crichton, 1798, as cited in 
Baumeister et al., 2011). In the chapter, “Attention, and its Diseases” (p. 254), Crichton notes 
that these conditions make people “incapable of attending with constancy to any one object 
of education” (p. 271), cause “mental restlessness”, “walking up and down”, and the 
“fidgets” (p. 272). Although Crichton was clearly describing disorders of attention, George 
Still, a British pediatrician, is usually credited with being the first person to describe the 
syndrome that has since been recognized as ADHD. Dr. Still gave a series of lectures on 
Some Abnormal Psychical Conditions in Children in 1902, in which he noted that even some 
children with normal intelligence may exhibit a “lack of attention which is very 
noticeable…[and which] no doubt accounts to a considerable extent for backwardness in 
school acquirements” (Still, 1902b, p. 1081 as cited in Baumeister et al., 2011).  
Since those original descriptions, the diagnostic characterization of ADHD has been revised 
numerous times. The three core symptoms are presently considered to be Inattention, 
Impulsivity and Hyperactivity (Baumeister et al., 2011; Biederman & Faraone, 2005; 
Davidson, 2008). Current prevalence estimates in the United States are 6-9% for children and 
adolescents and 3-5% in adults (Dopheide & Plizka, 2009). In the most recent National 
Comorbidity Survey, in which nearly 3200 adults, 19 to 44 years of age, were screened, the 
prevalence was 4.4% (Kessler et al., 2006).  
Unlike the childhood presentation, symptoms of hyperactivity and impulsivity are less 
prominent in ADHD-diagnosed adults than problems resulting from inattention, 
distractibility and disorganization (Dopheide & Plizka, 2009). The psychosocial difficulties 
caused by these symptoms have been well-documented, including marital and relationship 
problems, poor job performance and employment histories, and lower socioeconomic status 
(Biederman et al., 2011a; Fischer et al., 1990; Hechtman et al., 1984; Hechtman & Greenfield, 
2003; Ingram et al., 1999; Mannuzza et al., 1993; Spencer et al., 2007). Many adults with 
ADHD report frequent employment changes, difficulty in organizing finances, and 
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household and parental management responsibilities, dangerous driving, and unstable 
social relationships or social isolation (Weiss & Murray, 2003). Adults with ADHD are less 
likely to attain the same educational (and occupational) level as those without the diagnosis 
relative to what would be predicted based on their IQ, even with pharmacotherapy 
(Biederman et al., 2006; Biederman et al., 2008a; Mannuzza et al., 1993). Moreover, cognitive 
deficits of adults with ADHD, relative to adults without the diagnosis, do not change across 
the lifespan (Biederman et al, 2010). For example, although 84% of ADHD-diagnosed adults 
were statistically expected to be college graduates, only 50% reached this level of education 
(Biederman et al., 2008a).  
In adults, as with youth, first-line treatment options include the stimulant drugs, usually 
one of the many formulations of either methylphenidate (MPH) or amphetamine (AMPH) 
(Adler et al., 2007; Berman et al., 2009; Dopheide & Plizka, 2009; Dodson, 2005; Faraone et 
al., 2004; Paterson et al., 1999; Wender et al., 2011). These agents are the most efficacious 
drug treatments for ADHD, with large effect sizes, as measured by standardized rating 
scales in clinical trials. Methylphenidate and amphetamine formulations are considered 
similar in efficacy, with between 55 – 75 % of drug-treated patients (compared with 4 - 30% 
of placebo – treated patients) showing “clinically significant” improvement for up to 4 to 6 
weeks (Berman et al., 2009; Dopheide & Plizka, 2009). Available information indicates that 
on standard efficacy measures, amphetamine is at least equivalent may be superior to 
methylphenidate, and, that individuals with ADHD who don’t respond to methylphenidate 
will show significant improvement on amphetamine (Berman et al., 2009). When both drugs 
are tried, response rates may be as high as 85% (Dopheide & Plizka, 2009).  
Given their substantial and reliable clinical benefit for treatment of attention disorders, it is 
not surprising that prescriptions for stimulants have increased dramatically in the last few 
years. Between 1998 and 2005, there was a 133% increase in amphetamine product 
prescriptions and a 52% increase in methylphenidate products, for teenagers and 
preteenagers in the US (Setlik et al., 2009). According to US government data, from 1998 to 
2007, total amphetamine prescriptions increased by about 11.7 million, or 463% (Stix, 2009).  
The increase in stimulant prescriptions has resulted in a corresponding escalation of illicit 
use, particularly in college students, confirmed by numerous survey results (Advokat et al., 
2008; Arria & DuPont, 2010; Hall et al., 2005; McCabe et al.,  2005; Rabiner et al., 2008; 2009a, 
2009b;  Rabiner et al., 2010; Teter et al., 2003; Teter et al., 2005; Teter et al., 2006; Weyandt et 
al., 2009; White et al., 2006; Wilens et al., 2008). Wilens and colleagues (2008) report lifetime 
rates of diversion ranging from 16 to 29%, with medical prescriptions being given, sold or 
traded by students. Studies consistently show that most students report using stimulant 
medications, legally or illicitly, to improve academic performance, specifically to increase 
concentration, organization, and the ability to stay up longer and study. Because the 
rationale for illicit stimulant use in undergraduates is usually stated to be improvement of 
academic performance, rather than recreational, it is not always considered to be as 
problematic as other types of drug abuse. Unfortunately, this is not necessarily the case, and 
the medical and legal consequences of illicit stimulant use may be underappreciated (Arria 
& DuPont, 2010; Arria et al., 2008; Arria et al., 2011).  
The current escalation in stimulant diversion and misuse has initiated debate about the 
moral implications of using drugs to improve academic performance. Ethical discussions 
about taking drugs for ‘cognitive enhancement,’ have been the subject of several editorials 
www.intechopen.com
 
Do Stimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) Enhance Cognition? 
 
127 
and commentaries (Farah et al., 2004; Greely et al., 2008; Harris, 2009; Monastersky, 2008), 
which confirmed the widespread use of these agents, especially among college students, 
professionals and academics. Often the term is used very broadly to include drugs “…that 
improve memory, concentration, planning and reduce impulsive behavior and risky 
decision-making…”(Sahakian & Morein-Zamir, 2007, p. 1157). Thoughtful proposals for the 
‘responsible use of cognitive-enhancing drugs’ are espoused, calling for the scientific study 
of the expected risks and the benefits to be gained as well as the moral consequences of 
allowing broad access to pharmacological enhancement of mental capacities.  
These developments led the Ethics, Law and Humanities Committee of the American 
Academy of Neurology (AAN) to release a special report, "Responding to requests from 
adult patients for neuroenhancements,"  (Larriviere et al., 2009). According to lead author, 
Dan Larriviere, "A growing number of patients without illness believe they can improve 
their memory, cognitive focus and attention span by taking neuroenhancement drugs and 
are asking for prescriptions."  For the most part, these ‘neuroenhancers’ consist of stimulant 
drugs. “The drugs most commonly used for cognitive enhancement at present are 
stimulants, namely Ritalin (methylphenidate) and Adderall (mixed amphetamine salts), and 
are prescribed mainly for the treatment of attention deficit hyperactivity disorder (ADHD).”  
One of the strongest endorsements was expressed at the 60th Annual Conference of the 
Canadian Psychiatric Association in 2010 by Dr. Derryck Smith who presented a workshop 
on the subject and stated that psychiatrists should not hesitate to prescribe stimulants for 
neuroenhancement, if they wish. “We know they work….I think the effects of these 
medications are the same whether you have a medical diagnosis or not – they make 
everybody better” (Johnson, 2010). 
These developments illustrate the fact that, because stimulants have been used effectively 
for decades to reduce hyperactivity, impulsivity and inattention in children, and now 
adults, with ADHD, it has understandably been assumed that the drugs enhance long-term 
intellectual performance. Although that would seem to be a reasonable conclusion, it turns 
out that the scientific evidence for this conclusion is less than compelling. Recent reviews 
(Advokat, 2010; de Jongh et al., 2008; Repantis et al., 2010; Smith & Farah, 2011) provide 
very little experimental support for stimulant-induced cognitive enhancement. deJongh 
(2008) cites a few research studies that found some improvement in acute memory task 
performance with amphetamine in individuals with a low memory baseline, “…while high-
[memory]span subjects are either not affected or get worse” (p. 763). Similar results were 
summarized for methylphenidate, “With regard to MPH [methylphenidate], we were not 
able to provide sufficient evidence of positive effects in healthy individuals from objective 
tests” (Repantis et al., 2010, p. 204). A more detailed analysis of the scientific research on 
stimulant-induced cognitive effects in adults with and without ADHD (Advokat, 2010) also 
found little support for ‘cognitive neuroenhancement’ with these drugs. And recent articles 
in the New Yorker (Talbot, 2009) and Scientific American (Stix, 2009), describing the current 
resurgence of these agents confirm the modest intellectual benefit derived from their use in 
the ‘real world.’        
Accordingly, this selective review will discuss the evidence regarding cognitive effects of 
the two major stimulant medications, amphetamine (AMPH) and methylphenidate (MPH). 
We will emphasize information related to academic outcomes, incorporating some results of 
our own research on the neuropsychological and cognitive effects of stimulant medications 
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in college undergraduates, which show that these drugs do not reduce the academic 
disparity between ADHD-diagnosed and nonADHD-diagnosed students. We will discuss 
explanations proposed to account for the lack of cognitive improvement with stimulant 
drugs. Our goal is to shed some light on the apparent paradox of stimulant medications, 
namely: Why do drugs that acutely increase attention and concentration produce so little 
long-term intellectual benefit?   
2. Academic achievement of children and adolescents with ADHD 
The beneficial effect of stimulant drugs for classroom manageability of behavior-disordered 
children was first reported by Bradley (1937). During short, weekly, treatment periods he 
described increased productivity, comprehension and accuracy of the children, particularly 
in output of arithmetic problems. Since then, a vast literature has confirmed similar short-
term benefits. These medications have been shown to acutely increase the quality of note-
taking, scores on quizzes and worksheets, writing output and homework completion. The 
drugs”… reduce overactivity, restlessness and distractibility, enhance attention span or 
concentration and reduce impulsivity in responding to various tasks. Since a child who is 
attentive and better able to concentrate would presumably learn more from his classroom 
experiences, it should follow that these stimulant drugs would facilitate the scholastic 
performance of hyperkinetic children” (Barkley & Cunningham, 1978; p. 85). Nevertheless, it 
has been recognized for over 30 years that there is little evidence that these drugs improve 
the long-term academic achievement of ADHD diagnosed children.  
Barkley and Cunningham (1978) reported in the first review of the topic, that in long term 
studies lasting at least one year (and as long as 5 to 10 years) the drugs had little impact on 
academic outcome. A substantial proportion of ADHD-diagnosed children were in special 
schools or classes, had failed one or more grades, had reading or arithmetic difficulty and 
were having problems sitting still and studying. The authors concluded that, in spite of 
various procedural differences among the published studies, the outcomes were the same – 
stimulant drugs had little impact on the “…long-term academic outcome or adjustment of 
hyperkinetic children. If the drugs contribute positively, they appear to reduce disruptive behavior 
rather than improve academic performance” (p. 89-90, italics added). The same conclusion was 
reached in a subsequent review by Gadow (1983) and almost 8 years later, another group 
(Swanson et al., 1991) acknowledged that “Even though it has been established that 
stimulants do improve productivity, it is still unclear whether stimulants alone improve long-
term academic achievement, and, that… whether this widespread clinical practice has a long 
term beneficial effect on learning or academic achievement is still an open question” (p. 220). 
Carlson and Bunner (1993), incorporating the studies previously discussed by Gadow and 
Swanson concurred that stimulants facilitated acute academic performance of children with 
ADHD, but that long term treatment did not improve outcomes measured by the Wide 
Range Achievement Test (WRAT), the Peabody Individual Achievement Test (PIAT), the 
Stanford Achievement Test (SAT), and failed grades.  
There is now substantial evidence for persistent academic underachievement and poor 
educational outcome in children and adolescents diagnosed with ADHD (Loe & Feldman, 
2007). Children with ADHD have a consistently lower full-scale IQ than normal controls. 
They score significantly lower on reading and arithmetic achievement tests, use more 
remedial academic services, are more likely to be placed in special education classes, more 
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likely to be expelled, suspended or repeat a grade, compared with controls. By the time they 
reach adolescence, individuals with ADHD fail more grades have lower report card scores, 
lower class rankings, and worse scores on standardized achievement tests than “matched 
normal controls.”  They take more years to complete high school, and have lower rates of 
college attendance and graduation. Subsequent investigations of long-term outcomes of 
children with ADHD have only confirmed these conclusions and verified the modest 
academic impact of stimulant medications (Advokat, 2009; Barbaresi et al., 2007a; 2007b; 
Galéra et al., 2009; Scheffler et al., 2009; Van der Oord et al., 2008). 
Many investigators have considered possible reasons for this negative result, including the 
possibility that the stimulants might not affect the underlying cause of the academic 
dysfunction (Barkley & Cunningham, 1978). Gadow (1983) raised several issues in regard to 
the clinical use of the drugs. He discussed the possibility that doses required for behavioral 
control might be greater than needed to improve (and might actually worsen) cognition. He 
suggested that short-acting agents might wear off during a typical school day, such that 
information presented in the morning would be experienced while the child was under the 
influence of medication, while material presented in the afternoon might not be. He noted 
that the duration of treatment might not have been long enough to provide benefit for 
performance on achievement tests, because such tests assess concepts taught over several 
grade levels. He pointed out that previous studies did not take into account the contribution 
of co-morbid diagnoses, especially learning disabilities, the inclusion of different ADHD 
subtypes, or of non-responders. (However, as noted above, most patients do respond to 
stimulant medications if efforts are made to determine which drug would be most effective. 
A meta-analysis of the five studies in children that compared MPH to AMPH in blind 
crossover conditions found that about 37% of patients had a clearly better outcome on an 
amphetamine preparation, and 26% had a clearly better response to methylphenidate. The 
other 37% of stimulant responders could use either molecule with equal benefit, Greenhill et 
al., 1996). 
3. Academic achievement of college students with ADHD 
During the last 30 years, special education and disability laws have been passed enabling a 
variety of qualified students with disabilities to graduate from college preparatory 
programs in high schools and enter colleges and universities. Specifically, the Americans 
with Disabilities Act (1990), the Individuals with Disabilities Education Act (1975) and 
Section 504 of the Rehabilitation Act (1973) mandated educational accommodation for 
students with disabilities, and more students with disabilities are now successfully 
completing high school and attending college. Students with “hidden disabilities,” which 
includes ADHD, have represented the greatest increase. Because these students don’t have 
to report to disability offices it is difficult to determine the prevalence of ADHD, but the best 
estimate is that 25% of students getting disability services do so because of ADHD and that 
2% to 8% of the undergraduate population “self-report” ADHD symptoms (Weyandt & 
DuPaul, 2006; Wolf, 2001). 
Because most ADHD-diagnosed adults do not obtain a college degree, it is possible that 
those who do successfully progress through a college curriculum might differ from those 
who do not attend, or do not complete college. In other words, adults with ADHD who 
meet admission criteria for postsecondary education might be less cognitively impaired 
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than those who don’t. As noted by Frazier et al., (2007), not all ADHD-diagnosed 
individuals have academic deficits. Moreover, college students with ADHD might have 
more intellectual ability, better academic preparation and be able to compensate better 
than their non-collegiate cohort (Frazier et al., 2007). Such students might have developed 
a way to use stimulant medications more effectively, or to apply successful learning 
strategies, or both. If these individuals were able to benefit academically from stimulants 
it would be important to know how they did it. On the other hand, if the drugs are no 
more effective for this population than they were for elementary and high school 
students, it would be important to try to understand why they don’t provide the expected 
intellectual advantage. 
Moreover, the undergraduate population provides an excellent opportunity to evaluate 
some of the pharmacological explanations offered, in the past, for why stimulants did not 
improve academic outcome in children and adolescents. As noted above, one hypothesis 
was that the stimulant doses required to control the hyperactivity of ADHD-diagnosed 
children might be greater than doses that are most effective for improving cognition. 
However, unlike children, college students are less likely to be characterized as hyperactive, 
and more commonly diagnosed with, or to self-report, the symptom of inattention (Frazier 
et al., 2007; Norwalk et al., 2009; Rabiner et al., 2008; Schwanz et al., 2007) even without a 
specific diagnosis of ADHD (Lewandowski et al., 2008). Therefore, undergraduates should 
be able to determine the amount of stimulant medication that would presumably improve 
their attention and concentration without having to control hyperactivity as well. 
Previous reviews of children had also speculated that perhaps the short-acting agents didn’t 
provide sufficient coverage during a standard school day, and that daily variability in blood 
levels made it difficult to benefit from the intellectual advantages of the drugs. But duration 
of coverage is also less of a problem in undergraduate populations since long-acting 
formulations are now available, and regardless, college classes are usually not scheduled all 
day long. These considerations make arguments about dosage and variability of blood levels 
less persuasive, and would predict greater efficacy in the college population. 
Furthermore, therapeutic use of stimulants in children usually involves administration 
primarily during the school day, so that drug effects wear off in the evening, perhaps while 
homework is being done, to allow for sufficient sleep. This is not necessarily how college 
students, or other adults, routinely use stimulants. Surveys report that undergraduates often 
use the drugs to stay up at night to study or complete other projects. That is, adults are able 
to choose when they take the drugs, which might also promote more effective cognitive 
outcomes.  
The first review to describe the general academic functioning of college students with 
ADHD appeared only a few years ago and summarized results from 23 studies (Weyandt & 
DuPaul, 2006). They found that ADHD-diagnosed college students did not differ in IQ from 
those without ADHD, and were able to meet the demands of college courses. Nevertheless, 
they had significantly lower grade point averages (GPAs), reported more “academic 
problems,” and were less likely to graduate from college. Students who self-reported high 
levels of ADHD symptoms used significantly fewer coping strategies compared with those 
who did not (see also Reaser et al., 2007). They were less organized and ‘methodical,’ they 
had less self-control and discipline, and they procrastinated more. On laboratory 
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administered neuropsychological tests they showed significant deficits in attention, but 
were not different from normal students on other measures, such as the ability to be flexible 
and to maintain performance as task demands were varied. There was also no difference 
between those with and without ADHD on computerized tasks that assessed divided 
attention. However, the role of medications in these outcomes was not determined “…it is 
unclear what effects medications have on academic, interpersonal and psychological 
outcomes among college students” (Weyandt & DuPaul, 2006, p. 14). 
Since that review, numerous studies have reached similar conclusions. Some (Advokat et al., 
2008; Advokat et al., 2011; Blase et al., 2009) have found significantly lower GPAs in ADHD-
diagnosed college students relative to non-ADHD controls. Not surprisingly, higher levels 
of ADHD symptomatology are consistently associated with poor study habits, skills and 
academic adjustment, and greater self-reports of attention deficits (Norwalk et al., 2009; 
Schwanz et al., 2007). Recent surveys (Rabiner et al., 2008; 2009a; 2009b) show no difference 
between the ADHD-diagnosed undergraduates who used stimulant medications and those 
who didn’t, in regard to self-reported concerns with their academic performance, problems 
of inattentiveness, hyperactivity, depression or their social life. In other words medication 
had no discernible effect in the transition to college of students with ADHD (Blase et al., 
2009).  
For the last several years, our laboratory has been conducting research in undergraduates 
with ADHD to try to understand the cognitive effects of stimulant medications (Advokat et 
al., 2007; Advokat et al., 2008; Advokat et al., 2011; Advokat & Luo, unpublished; Barrilleaux 
& Advokat, 2009). Given evidence that suggests there is a positive relationship between the 
Grade Point Average of undergraduates and their working memory (Gropper & Tannock, 
2009) our efforts to clarify the cognitive actions of these drugs include studies of both, 
neuropsychological and academic performance of adult ADHD-diagnosed undergraduates. 
3.1 Neuropsychological assessment of ADHD-diagnosed college students 
Because inattention is a core symptom of ADHD, Barrilleaux and Advokat (2009) tested the 
effect of stimulant medications on attention with a repeated measures design, using the 
computerized, “Standard” version of the Conner’s Continuous Performance Test (CPT). In 
this version, letters of the alphabet are presented one at a time for 250 ms and the 
respondent is instructed to press the space bar for every letter except the letter X. ADHD-
diagnosed undergraduates (n = 13), and those without ADHD (n = 17), were tested twice on 
the CPT. For the ADHD-diagnosed participants one test was administered after they had 
taken their medication and the other when they were not on their medication.  
The results are summarized in Figure 1, which shows the average number of commission 
errors, that is, responses made when they should not have been (when the letter X 
appeared). This kind of mistake is often viewed as a measure of impulsivity. The left side of 
the figure shows the mean number of commission errors for the Control Group, on the first 
session (open bar), second session (dark bar) and the average of the two sessions (light bar). 
The right side of the figure shows the mean number of commission errors for the ADHD 
Group when they were Medicated (dark bar) and Non-Medicated (light bar). Non-
medicated ADHD-diagnosed adults made significantly more commission errors than 
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Fig. 1. Mean number of Commission Errors of Non-ADHD (Control) and ADHD-diagnosed 
undergraduates on the Continuous Performance Test (CPT). 
controls; when medicated, they performed as well as controls and significantly better than 
when they were unmedicated. These data illustrate the typical, classic impairment of 
attention found in numerous studies of ADHD diagnosed individuals, and the 
improvement produced by stimulant medications. 
In subsequent studies we assessed the effect of stimulant medications on several other 
neuropsychological tests. Unlike the CPT, performance on these tasks is influenced by 
practice; therefore, all of our other studies used a between-subject procedure. That is, in each 
experiment, three groups of undergraduate students were tested, one group without an 
ADHD diagnosis (Control), one group of ADHD-diagnosed students tested without 
medication (Off Meds) and one group of ADHD-diagnosed students tested while on their 
medication (On Meds). Several types of tests were administered, ranging from assessments 
of motor dexterity, verbal fluency, acquisition and retention of word lists, distractibility and 
problem-solving.  
Motor dexterity was tested with a mirror-tracing task. Each participant was asked to trace 
the outline of a star shape, which was presented on a computer screen. Tracing direction 
was set to mirror-reversed, such that the participant had to move the cursor in the opposite 
direction to that of the pattern lines in order to trace the pattern. That is, the participants had 
to learn over successive trials to trace the star shape as if it was being shown in a mirror.  
The results, summarized in Figure 2 below, showed no overall difference in latency among 
the three groups; all participants completed the task in the same amount of time. However, 
while the control group showed a significant decrease in latency across the five trials 
(p = .002) the two ADHD groups did not (Advokat & Vinci, unpublished data). That is, 
unlike nonADHD students, the performance of ADHD-diagnosed students did not improve 
significantly regardless of whether or not they were on stimulant medication. 
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Fig. 2. Median latency of mirror-tracing across 5 successive trials, in 3 groups of college 
students: nonADHD (Controls) (n = 19), ADHD-diagnosed students, tested without 
medication (Off Meds; n = 22) and ADHD-diagnosed students tested when on their 
medication (On Meds; n = 22).  
Our result is reminiscent of a report by Tucha & Lange (2004) that medication worsened 
some aspects of handwriting in ADHD-diagnosed children. In that situation, the 
handwriting impairment was attributed to a drug-induced enhancement of attention. That is, 
the results were interpreted to mean that, when they were on their medication, children 
with ADHD paid so much attention to the writing process that it impaired the fluency of 
their handwriting movements. It is tempting to speculate that a similar phenomenon 
occurred in our ADHD-diagnosed undergraduates. 
These observations show that although a decrease in behavioral activity is the most reliable 
effect of stimulant medications in ADHD, all types of behavioral activity are not reduced or 
improved by these drugs. ADHD-diagnosed children often show impairment in 
rudimentory motor function, including postural stability (Jacobi-Polishook et al., 2009), gait 
(Leitner et al., 2007), motor timing (Rubia et al., 2003) and other neurological reflexes (Stray 
et al., 2009), which is generally alleviated by stimulants. However, improvement is not 
always complete, or evident under all conditions. For example, Pelham et al., (1990) 
evaluated methylphenidate in boys with ADHD while they were playing a series of softball 
games. Although the drug improved the children’s attention during the games, it did not 
affect their actual performance or skill. 
There is a vast literature describing experimental efforts to determine the neurocognitive 
deficits associated with ADHD, and how they might be affected by stimulant drugs. While 
the technology and the conceptual models have become more sophisticated, progress has 
been modest. Recent analyses of stimulant effects on neurocognitive impairments in ADHD 
children (Doyle, 2006; Gualtieri & Johnson, 2008; Swanson et al., 2011) have essentially 
confirmed early observations (Robbins & Sahakian, 1979): stimulants are most likely to 
improve performance of ADHD diagnosed individuals in the domains of reaction time and 
processing speed, rather than in more complex functions requiring “…inhibition, working 
memory, strategy formation, planning and set-shifting” (Swanson et al., 2011, p. 211).   
Several reviews have assessed neuropsychological functions in the adult population with 
ADHD (Frazier et al., 2004; Hervey et al., 2004; Schoechlin & Engel, 2005; Woods et al., 2002) 
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and shown modest, but inconsistent impairment. Furthermore, these deficits are also not 
always eliminated by stimulant drugs. Turner et al., (2005) tested ADHD adults, before and 
after methylphenidate, on attention tests and one memory task, and did not find 
improvement. Müller et al., (2007) reported that medicated ADHD adults were still 
impaired, relative to controls, on several neuropsychological measures such as the Tower of 
London test of ‘planning ability,’ and the Stroop test of ‘distractibility.’ Kurscheidt et al., 
(2008) reported retrospective results of 34 patients on chronic methylphenidate. Compared 
to baseline, the drug significantly improved attention and ‘verbal memory performance’ 
after months of treatment – while other tasks were not affected. Tucha et al., (2011) reported 
differences between nonADHD and ADHD-diagnosed adults on the Tower of London task 
and one that measured verbal fluency. In this case, MPH did improve performance of 
ADHD adults on the Tower of London, but not on the verbal fluency task. Biederman et al., 
(2008b) administered a battery of tests to non-ADHD subjects and separate groups of 
ADHD patients who were either on or off medication. They found the largest beneficial 
effects on sustained attention (vigilance) and verbal learning, whereas stimulants did not 
significantly improve measures of interference (i.e. distractibility) or processing speed (on 
the Stroop test).  
We recently conducted a study of the most commonly used neuropsychological tasks in our 
undergraduate population, including a verbal fluency measure, the Tower of London 
planning task and the ‘distractibility task,’ the Stroop test. The only significant difference 
among the groups was on the Stroop test. This test involved three sets of stimuli, presented 
on a computer screen. The word reading stimuli consisted of three color words (blue, red, 
and green) in black ink, which the participant read aloud. In the color naming test, the 
stimuli were a series of five Xs (i.e., XXXXX) in all blue, all red, or all green ink, and the 
participant read aloud the ink color. Finally, in the incongruent color naming stimulus set 
(interference condition), stimuli consisted of the color words blue, red, and green printed in 
an incongruent color. The participant had to name the color of the ink in which the word is 
printed, not the word color. 
We found modest, but statistically significant differences on two measures of the Stroop test. 
As shown in the top half of Figure 3, below, on the Stroop Interference test, the Control 
(n=35) and ADHD (On Med) groups (n=36) reacted significantly faster than the ADHD (Off 
Med) group (n=33). Part B shows that the Control group made slightly, but significantly, 
fewer mistakes (was more accurate) than the ADHD (Off Med) group, while the ADHD (On 
Med) group did not differ from the other two groups. 
These data are consistent with other studies showing first, that adults (Johnson et al., 2001; 
King et al., 2007; Murphy et al., 2001; Rapport et al., 2001) as well as children with ADHD 
(Bedard et al., 2002; Prehn-Kristensen et al., 2011), are impaired on the Stroop interference 
measure compared to control populations. Second, Biederman et al., (2008b) showed that 
medication did not normalize Stroop interference control in young adults with ADHD. In 
our study, the Interference RT of the On Med group was normalized. Yet, the Interference 
accuracy of the On Med group, although improved, was still not significantly different from 
either of the other two groups. Considering the small absolute difference in magnitude, it is 
surprising that the drugs did not fully eliminate the accuracy deficit along with the RT 
deficit. One possibility is that the reduction in RT increased impulsivity, which might have 
impaired a corresponding improvement in accuracy.  
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Fig. 3. Top:  Stroop Interference Reaction Time (RT – milliseconds). The Control group 
(n=35) and ADHD (On Med) group (n=36) reacted faster than the ADHD Off Med group, 
p<0.05 (n=33). Bottom:  Stroop Interference Accuracy. The Control group made fewer 
mistakes than the ADHD (Off Med) group in interference, p<0.05, and the ADHD On Med 
group did not differ from the other two groups. Bars represent standard error of the mean. 
In brief, our results showed that undergraduate students with ADHD did not show 
significant deficits in verbal fluency or planning ability, compared to normal students. The 
only statistical effects occurred in the Stroop test, and the absolute differences were 
extremely small. Even so, while medications improved the performance of ADHD students 
they did not eliminate the deficit, nor did they help ADHD students perform better than 
normal students in domains of functions where no deficits were found. It is possible that 
more differences might have been seen in measures other than the Stroop test, if the groups 
were larger. However, our group sizes were comparable to those typically used. A more 
likely possibility is that our ADHD population may have had less severe symptomatology 
than participants in other studies, cited above, who appeared to be clinic patients.     
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Although research shows practically no cognitive benefit of either methylphenidate or 
amphetamine on acquisition (Advokat, 2010), there is some evidence that stimulants might 
improve retention of previously acquired information (Izquierdo et al., 2008; Soetens et al., 
1993; 1995; Zeeuws & Soetens, 2007). In a series of experiments by Soetens and colleagues, 
nonADHD adult males received placebo and amphetamine, in a within-subject 
experimental procedure. After each drug, participants were asked to study word lists and 
were tested at various times afterward to assess how many words they could recall. The first 
test took place immediately after presentation of each of 10 word lists, the next test was 
given at the end of each daily session (after all the lists), and other tests were given after 1 
hour, after 1 day, and after 3 days.  
There was no drug effect after immediate recall or at the end of the daily session, that is, no 
effect of amphetamine on acquisition of the words. But there was a significant effect of 
amphetamine on recall 1 hour after the end of the session, and at 1 and 3 days later. These 
results were interpreted to mean that although amphetamine did not improve learning 
(acquisition), it facilitated the consolidation of information that had already been learned, and 
that the beneficial effect on consolidation was responsible for the improved retention of the 
words at 1 hour and 1 and 3 days later. The term ‘consolidation’ refers to the process by which 
memory undergoes a change from the short-term, labile, form to a long-term, stable form.  
We attempted to replicate this phenomenon in our undergraduates. Although we could not 
administer stimulant drugs to nonADHD participants, it was possible that ADHD students 
might have a memory impairment that could be reduced by stimulants. In our study, 
participants from each of the three experimental groups viewed five sets of ten words. After 
each list of 10 words the participants were asked to write down as many words as they could 
remember (Test 1). After the fifth set of words was presented, participants were ‘distracted’ by 
performing a second behavioral task (the mirror tracing task, discussed above). Following the 
mirror tracing task, participants were asked to write down as many of the 50 words as they 
could remember (Test 2). Last, participants were contacted on the next day and asked a third 
time to recall as many words as they could remember from the word lists (Test 3). As shown in 
Figure 4, below, there was no difference among the groups. ADHD students did not differ 
from nonADHD students in regard to acquisition or retention of the word lists at any time 
point, regardless of whether or not they were on medication during the test.  
In summary, our assessment of neuropsychological function in undergraduates with ADHD 
showed the expected impairment on the classic, CPT test of attention, which was normalized 
with stimulants. We also observed a previously unreported motor deficit (on the mirror 
tracing task), which was not improved by stimulants. We saw two types of deficit in the Stroop 
test of ‘distractibility,’ namely, a slower reaction time, corrected by stimulants, and a very 
slight impairment in accuracy, which was not eliminated by stimulants. These results are 
consistent with the literature, and illustrate the counterintuitive nature of stimulant effects in 
ADHD. That is, although cognitive processing speed and basic aspects of attention are 
normalized, even slight deficits in ‘distractibility’ are not eliminated. Finally, although we did 
not replicate the memory improvement that had been shown in nonADHD adults with 
amphetamine, we also did not see any deficits in that task in our ADHD students. It is 
appreciated that because they were college students, our ADHD population might have had 
very mild symptoms and were perhaps not representative of the typical ADHD adult. We 
could not confirm their diagnoses. However, if that was the case, we would not expect them to 
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Fig. 4. Retention of word lists in nonADHD students (Control), ADHD students, who were 
tested when they were not on medication (Off Meds) and ADHD students who were tested 
when they were on their medication (On Meds). Retention was tested immediately after 
each list of 10 words (Test 1), about 20 minutes after the 5 lists (Test 2) and 1 day after the 5 
lists (Test 3). There was no difference among the groups in the number of words recalled on 
any test.  
be academically impaired, relative to their nonADHD counterparts, especially considering that 
the stimulants exert the same types of effects in those with or without the diagnosis. The data 
obtained regarding academic performance, discussed below, show that that is not the case.   
3.2 Academic performance of ADHD-diagnosed college students 
The ADHD-diagnosed undergraduates we tested showed very little neurocognitive 
impairment. Perhaps the fact that they had successfully entered college meant either that 
they had less severe symptomatology or that they were able to gain some academic benefit 
from the stimulants (or both). If the latter, it would be important to find out how, so that 
their strategies could be broadly implemented. On the other hand, in view of growing 
concerns about escalating abuse and diversion of stimulant drugs, it would be equally 
important to know if these medications did not provide any academic advantage for 
ADHD-diagnosed undergraduates.      
In these investigations we compared the self-reported drug use (both licit and illicit), study 
habits and strategies of ADHD-diagnosed and non-diagnosed undergraduates. We 
administered questionnaires to find out if there was a substantial difference in how these 
two groups approached their schoolwork, and, if there was any corresponding difference in 
their respective Grade Point Averages (GPA) and other measures of academic achievement.  
In the first study (Advokat et al., 2008) we asked about the legal use of prescription 
stimulants by undergraduates diagnosed with ADHD, and compared that with illicit use by 
students without the diagnosis.  
A total of 1550 undergraduate students completed at least part of the survey, with 163 
(10.5%) of these students reporting a diagnosis of ADHD (the ADHD Group). Among the 
remaining 1387 respondents, 591 (43%) reported that they used stimulant medications 
without a prescription (the No ADHD, Illicit Use group) while 794 (57%) stated they did not 
use stimulant medications illicitly (the No ADHD, No Illicit Use group).  
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As shown in Figure 5, the three groups differed significantly in response to the question: 
“Do ADHD medications help academic performance,” in that a significantly greater 
proportion of the ADHD, and No ADHD Illicit Use groups, endorsed this statement 
compared with the No ADHD No Illicit Use group. The fact that a majority of illicit users 
endorsed this statement supports the conclusion that the drugs were primarily used as 
study aids. For that matter, a surprising 12% of illicit users in that study reported that they 
believed they also had ADHD. That might even be true, but we have no way of verifying 
that assumption.  
 
Fig. 5. Percent of undergraduates who agreed with the statement “Do ADHD Medications 
Help Academic Performance.” *Significantly fewer students in the No ADHD No Illicit Use 
group endorsed this statement compared to each of the other two groups. 
Figure 6 shows that the same groups also differed significantly in GPA, in that the GPA of 
the ADHD group (3.05, out of a possible 4.0) was significantly lower than that of the No 
ADHD Illicit Use group (3.15) and the No ADHD No Illicit group (3.19).  
 
Fig. 6. Mean Grade Point Average (GPA) of each of the three groups. * The GPA of the 
ADHD group (3.05, out of a possible 4.0) was significantly lower than that of the No ADHD 
Illicit Use group (3.15) and the No ADHD No Illicit group (3.19).  
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It should be noted that we cannot tell from these data how many students in the ADHD 
group actually used stimulant medications. Nor can we tell if the GPA of both groups that 
used stimulant drugs would be even lower if those students didn’t use the drugs. That is, 
we can’t tell if the drugs were effective, either because they worked or because the students 
believed the drugs worked.  
Last, Figure 7, below, summarizes reported recreational drug use of Tobacco, Alcohol, and 
Marijuana of these same groups. In each case there was a significant difference among the 
groups in frequency of drug use. For each drug, post-hoc comparisons indicated that a 
greater percent of the No ADHD Illicit Use and ADHD groups used these drugs compared 
with the No ADHD No Illicit Use group. Only in the case of alcohol did the ADHD group 
use less than the illicit stimulant users, although they still drank significantly more 
frequently than those who didn’t use stimulants illicitly.  
Overall, recreational drug use in our student sample was very modest. Nevertheless, the 
significant difference between ADHD-diagnosed and Non-diagnosed-non-stimulant users 
was unexpected, and we can only speculate about the reasons for this result. First, perhaps, 
believing that their symptoms are effectively controlled by stimulant medications, these 
students feel they are able to use other drugs responsibly. Second, because of the 
impulsiveness that often characterizes ADHD, these young adults might not be able to 
inhibit other drug use, especially if the drugs are offered in the social context of a party, or 
other nonacademic environment, when students might not be using their stimulants 
“medically.” Third, considering that alcohol and marijuana are sedating, ADHD students 
might use them to counteract the stimulatory effect of the medications, that is, to help them 
relax or go to sleep. It is also possible that those with ADHD (and nonADHD, illicit users) 
have comorbid conditions (such as conduct disorder) or other risk factors that increase use. 
These data show that, although the GPA of the ADHD students was significantly lower than 
that of the nonADHD–Illicit users, both groups endorsed significantly greater recreational 
drug use than students who did not use stimulant drugs illicitly. Unfortunately, we can’t tell 
from these data if perhaps ADHD students were more vulnerable than nonADHD students 
to a detrimental effect of recreational drugs on academic performance, or if both groups 
might have had a better GPA without such use.  
Our results showed that a majority of ADHD diagnosed students (and many without the 
diagnosis) believed that stimulants improved academic performance. And although the 
GPAs of ADHD students were statistically lower than those of nonADHD students that did 
not mean the stimulants didn’t help. The aim of our next study was to find out more about 
the influence of stimulant medications on academic outcome. We surveyed the self-reported 
study habits and strategies of ADHD-diagnosed and non-diagnosed undergraduates, to 
determine if they differed in response to the academic demands of the college curriculum 
(Advokat et al., 2011).  
A total of 143 students without ADHD (Control group) and 92 students with an ADHD 
diagnosis (ADHD group) completed the survey. The average age of the two groups, 
approximately 21 years, did not differ, and most participants in each group were Caucasian 
(81.8% and 89.1% for Control and ADHD, respectively), although there were significantly 
more males in the ADHD group (38% compared to 17.5%).  
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Fig. 7. Percent of respondents in each group as a function of the frequency with which they 
used tobacco, alcohol and marijuana. *In each case, the ADHD and the No ADHD Illicit Use 
groups endorsed significantly more use than the No ADHD, No Illicit Use group. The 
ADHD group also used alcohol significantly less than the No ADHD Illicit Use group. 
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The average age at which the ADHD participants received the diagnosis was between 15 
and 16 years, about 5 years before entering college. While nearly 98% of this group had 
taken ADHD medication, only 78.3% (72 respondents) were currently using the drugs, while 
19.6% (18 respondents) stated that they were not currently taking the medications. When 
asked why they might not be taking stimulant medications, the majority cited the problem 
of side effects. Although specific side effects were not always mentioned (“I did not like the 
way it made me feel; …make me feel crappy; the negative side effects outweigh the 
positives”), some individuals cited headaches, irritability, temporary heart rate elevation, 
nausea, sleep interference and ‘antisocial’ feelings as examples of undesirable reactions. Five 
in this subgroup also stated that they either didn’t need the drugs anymore, or, they wanted 
to see if they didn’t need them anymore.  
Similar to the previous study, more than 90% of the students with ADHD endorsed the 
statement that medications helped them academically. Most of them stated that the drugs 
helped them to focus or to concentrate better i.e. pay attention, stay awake, and organize 
their studying. However, relatively few students (n = 6) with ADHD specifically stated that 
they took medication to avoid distractions.  
With regard to academic performance, Control and ADHD students took the same amount 
of Advanced Placement Credits (an average of 8.1 for the Controls and 6.7 for ADHD 
students). For those few in each group who took the SAT (Scholastic Aptitude Test, a national 
exam sometimes required for college admission), there was no difference in their self-reported 
SAT scores. They did not differ in the number of scholarships awarded, were enrolled for the 
same number of semesters (between 6 and 7), took the same number of credits per semester 
(about 14.5), and studied the same number of hours per week (about 9.5 to 10.5).  
These two groups also did not differ statistically on many of their answers to questions 
about study habits. The same proportion of both groups believed that they studied “about 
the same as” other students and that the quality of their class notes was either “better” or 
“the same” as those of other students. The same proportion in each group did not review 
their notes either before or after class, and only “sometimes” read assigned reading before 
class. About three-quarters of each group stated that they were ”somewhat accurate” at 
predicting how well they did after exams. The fact that there was no statistical difference 
between nonADHD-diagnosed students, and those with ADHD in response to these questions 
suggests that the diagnosis did not seem to promote better study habits in the ADHD group. 
However, the Control and ADHD groups did differ on several academic variables, as shown 
in Table 1. (Although the values of ADHD students who stated that they did not take 
stimulant medications are shown for some of the variables, the statistical results are based 
on a comparison between Control and all ADHD students). 
As in our previous report, the college GPAs of ADHD students were statistically lower than 
that of the Controls. In this study we also found that ADHD students had a significantly 
lower high school GPA and ACT score than Controls. Although small, this difference was 
detected in spite of the fact that a minimum high school GPA and ACT score were required 
for admission to the university. The table also shows that ADHD students were significantly 
more likely to  withdraw from a class, to say that they were worse than other students at 
planning for and completing class assignments, frequently taking class notes, studying 
ahead of time for exams and avoiding distractions.  
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 Control  (n)  
(N = 143) 
ADHD  (n)        ADHD No Meds 
(N = 92)                 (n = 18) 
P  ** 
High School GPA 
College GPA 
ACT Score 
Times Withdrawn from a Class 
 
Planning for class assignment  
  Better 
  Worse 
  About the same 
 
Completing class assignment  
  Better 
  Worse 
  About the same 
 
Frequency of note-taking  
  Nearly every lecture 
  Sometimes 
  Read someone else’s notes 
  Neither take notes nor read other’s notes
 
When you study for an exam do you  
  Study well before the exam 
  Study in the day or two before the exam 
  Both situations could happen 
 
Avoiding distractions while studying  
  Better 
  Worse 
  About the same 
3.55 ± 0.47 (141)
3.12 ± 0.49 (142)
25.45 ± 5.2 (124)



























3.38 ± 0.43 (89) 
2.94 ± 0.44 (91)      2.90 ± 0.46   
24.1 ± 3.0 (80)        24.6 ± 2.61 (16) 
2.3 ± 2.4 (89)          3.28 ± 3.89 (18) 
 
 
26.1 (24)                   27.8 (5) 
35.9 (33)                   38.9 (7) 
38.0 (35)                   33.3 (6) 
 
 
30.4 (28)                  33.3 (6) 
19.6 (18)                  22.2 (4) 









25 (23)                      16.7 (3) 




16.3 (15)                   11.1 (2) 
64.1 (59)                   66.7 (12) 































* Unless otherwise indicated, scores are percent; ** p values are for Control vs all ADHD respondents 
GPA and ACT scores are all self-reported 
Table 1. Academic Variables That Differed Between Controls and ADHD-Diagnosed 
College Students * 
These results show that Control and ADHD-diagnosed students differ in some of their self-
reported study habits. But these data alone don’t tell us if these endorsements are relevant to 
the academic achievement of either group. In other words, we didn’t know if the statistically 
significant differences in professed study habits were related to the respective GPAs. We 
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therefore analyzed the answers to some of the questions on which the two groups differed 
as a function of GPA. The results are summarized in Table 2.  
There were significant differences within the groups on several measures. Control students 
who stated they were ‘better’ at planning and completing assignments, took ‘frequent’ notes 
in class and ‘avoided distractions,’ had higher GPAs than those who said they weren’t, 
suggesting that their judgments were accurate. However, the GPA of Control students did 
not differ as a function of whether or not they said that they studied ‘ahead of time’ or just 
days before an exam. In other words, Control students did not ‘pay a price’ in GPA for 
waiting until a few days before exams to study. In contrast, the GPA of ADHD students 
who stated that they studied ‘well before’ an exam, was significantly higher than the GPA of 
those (the majority of this group) who said they studied in the ‘day or two’ before an exam. 
Unlike Control students, ADHD students did ‘pay a price’ for waiting until the exam was 
imminent before they began to study. This difference seemed to epitomize a fundamental 
behavioral impairment in ADHD, so we examined it further.  
 
Variables Control ADHD   
Planning for class assignment                   
  Better 
  Worse 
  About the same 
Completing class assignment  
  Better 
  Worse 
  About the same 
Frequency of note-taking  
  Nearly every lecture 
  Sometimes 
  Read someone else’s notes 
When you study for an exam do you      
  Study well before the exam 
  Study in the day or two before the exam 
Avoiding distractions while studying     
  Better 
  Worse 
  About the same 
* 
3.26 ± 0.43 (46) 
2.92 ± 0.52 (19) 
3.06 ± 0.50 (77) 
* 
3.30 ± 0.44 (48) 
2.49 ± 0.82 (3) 
3.02 ± 0.47 (90) 
* 
3.13 ± 0.46 (117) 
3.06 ± 0.57 (23) 
2.25 ± 0.35 (2) 
NS 
3.12 ± 0.48 (56) 
3.10 ± 0.50 (86) 
* 
3.30 ± 0.51 (24) 
2.91 ± 0.50 (48) 
3.18 ± 69 (69) 
* 
3.09 ± 0.39 (23) 
2.79 ± 0.41 (33) 
2.93 ± 0.48 (35) 
* 
3.04 ± 0.42 (28) 
2.67 ± 0.39 (18) 
2.97 ± 0.46 (43) 
NS 
3.0 ± 0.46 (57) 
2.86 ± 0.42 (24) 
2.76 ± 0.39 (5) 
* 
3.16 ± 0.35 (22) 
2.86 ± 0.47 (64) 
NS 
3.0 ± 0.44 (15) 
2.88 ± 0.46 (58) 
3.07 ± 0.40 (17) 
* p < 0.05, for GPAs within each of the 2 groups, as a function of their answers to each question 
Table 2. Factors Affecting College GPA ± SD (n) of Control and ADHD-Diagnosed Students 
Because we had asked the students if they were taking ADHD medications, we could 
distinguish between those ADHD students who said they did (n = 72) from the smaller 
group, who said they didn’t (n = 18). The existence of these subgroups allowed us to 
compare the GPA of ADHD students who did or did not take the drugs, as a function of 
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whether or not they studied ahead of time for exams. This resulted in 4 groups, with the 
following GPAs (± Standard Errors):  Those who took the medications, and did not study 
ahead of time (n = 47), 2.88 ± 0.48; those who used the drugs and did study early (n = 19) 
3.15 ± 0.35; those who did not take the medications, and did not study ahead of time (n = 
15), 2.84 ± 0.47; and those few who did not take the drugs but did study early (n=3) 3.19 ± 
0.36. A two-way analysis of these GPAs found no effect of medication, but a statistically 
significant effect of study interval, (F = 4.06, p = .047).   
This preliminary analysis showed that, if ADHD students utilized the well-known strategy 
of studying ahead of time for exams, they could overcome their achievement deficit, even if 
they didn’t take stimulant medications. In spite of the fact that only 3 students ‘studied ahead of 
time’ without using the drugs, their GPA was comparable to that of the 19 undergraduates 
who did take the drugs in addition to using good study habits. Obviously this outcome 
needs to be validated in a larger group of individuals. But, the data suggest the optimistic 
implication that the GPA disparity between ADHD and nonADHD students could be 
eliminated if ADHD students were able to develop well-established study habits.  
Unfortunately, it is not clear from these data alone if taking stimulant medications actually 
helps ADHD students to develop beneficial study habits. That is, do the stimulant drugs 
help students to plan ahead, e.g., to begin studying ahead of time so that they can 
compensate for their cognitive deficit?  If so, why didn’t this behavior occur in more of the 
ADHD students?  
These data provide preliminary empirical evidence that, as with elementary and high school 
students, adult college students with ADHD are less likely to reach the same academic level 
as their non-ADHD counterparts, even when they use stimulant medications. Stimulants do 
not necessarily normalize academic achievement, even when they can be administered at 
the most appropriate doses and durations for maximum efficacy, and, even in a population 
that is considered to be less intellectually impaired than the typical adult with ADHD.  
It should be noted that even those ADHD students who did not engage in good study habits 
were not failing. Their average GPA was just above a ‘C,’ which means they were able to 
progress towards graduation at a normal pace. On the other hand, the absolute difference 
between the GPAs of ADHD students and Control students was not very large, only about a 
third of a grade. Yet this difference was consistent, and it is surprising that the stimulants 
were not more effective in narrowing the gap. Why aren’t the stimulant medications more 
cognitively effective?   
4. Discussion 
In their consideration of this question, Barkley and Cunningham (1978) raised the possibility 
that the problem with stimulant medication might be that it made hyperactive children less 
aware of their environment, perhaps more intellectually ‘constricted’ and rigid and less 
inquisitive or interested in learning. Similarly, Gadow noted that stimulant drugs might 
produce ‘cognitive perseveration,’ akin to amphetamine-induced stereotypies (that is, the 
repetitive performance of an invariant behavioral sequence). Subsequently, Carlson and 




Do Stimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) Enhance Cognition? 
 
145 
Robbins and Sahakian (Robbins & Sahakian 1979; Sahakian & Robbins, 1977) provided an 
insightful discussion of this point, proposing that stimulant-induced stereotypy might play 
a role in the behavioral effect of the stimulants. They noted that, “…although stereotypy 
may improve performance in certain situations, perhaps by focusing or channeling 
“attention,” it may also lead to impairments when behavioral flexibility is required” (p. 944). 
Their review summarized results of numerous studies in ADHD-diagnosed children, 
including activity measures and complex motor tasks, cognitive tasks, intelligence tests, 
verbal fluency and language tests, and attention and vigilance tests. Across all these 
categories, the greatest improvement from stimulants was seen in activity tests (measured 
with photo cells, actometers and stabilimetric apparatus’) and the least amount of 
improvement occurred in the problem-solving test category.  
Subsequently, these researchers obtained evidence for stimulant-induced ‘cognitive 
perseveration’. They conducted a study in children who had been on methylphenidate for 4 
to 29 months (Dyme et al., 1982). Each child was tested 3 times, first, under a ‘no drug’ 
practice condition, then on two trials of either placebo or drug (1 mg/kg). The tasks 
included a test of ‘flexibility of thinking,’ the Wisconsin Cart Sort Test (WCST), involving a 
set of response cards which could be sorted according to color form or number. Subjects 
were not told which variable was correct for sorting, only when the choice was right or 
wrong; they had to figure it out for themselves. After 10 cards were sorted correctly the 
examiner changed the sorting variable without telling the subject who then had to 
determine the new ‘correct’ sort. Subjects were scored on the number of errors as well as 
correct cards sorted. ‘Perseverative Errors’ were mistakes in which the subjects sorted 
according to a prior category after they had already been told that sort was “wrong.” 
The results showed that although all children improved their speed or performance on 
measures of attention, none improved on this flexibility measure and most got worse. This 
result has since been replicated (Tannock & Schachar, 1992), although not in all cases 
(Swartwood et al., 2003). Moreover, Tannock and Schachar (1992) found that this 
impairment recovered rapidly (that is, tolerance developed).  
Nevertheless, consistent with the WCST data, Schroeder et al., (1987) found that 
methylphenidate impaired performance of 15 normal male volunteers, 18 – 40 years old, on 
a unique procedure. “The task was an arcade-like game called Telekinesis Star Wars, which 
was highly engaging.., as opposed to the more monotonous tasks commonly used in these 
neuropsychological studies.” Several measures were obtained from the subject’s 
performance in this game, which reflected the strategies used by each player, and indicated 
if they were improving or not. In each case, the data showed that subjects given 
methylphenidate, at doses of 0.15 or 0.30 mg/kg, were poorer than controls at improving 
their performance throughout the test session. Drug-treated subjects did not develop 
“adaptive problem-solving strategies selected by controls.”    
Similarly, Burns et al., (1967) also described a learning task that was worsened by 
amphetamine. Subjects were seated in front of 8 lights, each placed above a key that 
controlled one of the lights. The subjects “had to learn which single key was the correct 
response to each [of 8] light[s] when the keys were randomly assigned, except that the 
correct button was never in front of the light associated with it.” The session consisted of 840 
trials balanced for frequency of light/key pairings. In this situation, the d-amphetamine 
group showed a significantly slower rate of learning than the placebo group. Such results 
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suggest that, due to their profound effects on attention, stimulants may impair adaptive 
problem-solving ability, perhaps by inducing perseverative behavior. 
Similarly, because attentional ‘overfocusing’ and creativity may be inversely related, there 
has been concern that stimulants might decrease creativity in people using the drugs for 
cognitive enhancement. Several studies have explored this possibility, mostly in children, 
with mixed results. Swartwood et al., (2003) found that MPH actually worsened the scores 
of ADHD-diagnosed children on a battery of tests assessing ‘divergent thinking,’ relative to 
their nondrug tests. Funk et al., (1993) saw no effect of methylphenidate on a test battery of 
‘creative thinking,’ in young boys, relative to a nonADHD comparison group. Solanto and 
Wender (1989) also reported that methylphenidate maintained ‘divergent thinking’ in 
ADHD-diagnosed children when the children were tested over several days, relative to the 
decline that occurred on nondrug days. And Douglas et al., (1995) found that “… MPH 
doses up to 0.9 mg/kg had an increasingly positive effect on measures of mental flexibility 
and other cognitive processes” in 17 ADHD children.  
To our knowledge, there are no studies of stimulant effects on creativity in ADHD adults. 
However, Farah et al., (2008) examined the effect of amphetamine in 16 nonADHD adults on 
four tests of creativity, “two tasks requiring divergent thought and two requiring 
convergent thought (p. 542).”  Only performance on the convergent tasks was affected, and 
the effect depended on baseline performance. The results suggested that people who are 
already very creative might be unaffected or even impaired, whereas those who were not 
very creative to begin with might improve with stimulants. It remains to be seen however 
whether ADHD-diagnosed adults (or even children for that matter) are actually less 
‘creative’ than their nonADHD cohorts.     
Stimulant-induced perseveration and impairment of cognitive flexibility (creativity) have 
been the most commonly proposed reasons for why these drugs produce so little long-term 
cognitive benefit. But, stimulants are also sympathomimetics, that is, they produce the same 
effects as the sympathetic transmitters that mediate arousal and alertness. This physiological 
action is rarely discussed in regard to ADHD, perhaps because stimulants are used 
therapeutically to decrease rather than increase behavioral activity. But arousal is known to 
have significant effects on memory; moderate levels of arousal enhance memory while too 
much arousal impairs memory. 
Recent studies of Brignell and colleagues (Brignell et al., 2006; 2007) illustrate the possible 
relevance of this approach. In one study, separate groups of subjects were given either 
placebo or methylphenidate while undergoing classical conditioning of a skin conductance 
response. Methylphenidate did not impair conditioning; the subjects who received the drug 
did acquire the conditioned response. However, the drug increased the number of responses 
to both, the non-conditioned stimulus and conditioned stimulus, compared to the placebo 
group. This was described as a “general pattern of methylphenidate-induced arousal 
increasing propensity to respond.”  It was concluded “methylphenidate decreased 
responses to highly arousing stimuli and increased responses to the less arousing stimuli 
(512).”      
A second study suggests that this phenomenon might be relevant to the issue of stimulants 
and cognition. In this case, subjects were presented with a series of slides that were designed 
to tell a story that included a very ‘emotional’ component. One week later the participants 
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returned to answer multiple choice questions about the story. Placebo-treated subjects 
showed the expected enhancement of memory for the emotional slides, relative to the 
neutral slides. But methylphenidate-treated subjects did not show this increase in memory of 
emotional material, even though the drug had increased their pulse and blood pressure. 
Unlike placebo-treated subjects, those given the drug showed comparable retention across 
all phases of the story. In other words, methylphenidate eliminated the preferential 
retention of the information on the emotional slides. These data suggest that the 
physiological arousal produced by stimulant drugs may be relevant to the fact that they do 
not seem to provide lasting cognitive benefit. 
5. Conclusion  
There is a paradox in regard to the use of stimulant medications indicated for the treatment 
of ADHD. On the one hand, there is much recent medical, legal and ethical concern about 
escalating use of these drugs, both licit and illicit, primarily to enhance cognition. On the 
other hand, there is surprisingly little evidence that the stimulant drugs truly are ‘cognitive 
enhancers.’ Results from neuropsychological studies confirm that while stimulants 
apparently increase attention in adults diagnosed with ADHD, the drugs produce very 
modest and inconsistent improvement on a variety of other neuropsychological tasks. 
Although responses may be faster, inaccuracy and errors persist, especially on tests of 
‘distractibility.’ Intuitively, it would seem logical that drugs that improve attention and 
concentration should promote learning and academic achievement. Yet, for more than 30 
years data have shown that this is not the case in regard to children and adolescents. 
Evidence presented here supports the same conclusion for adult college students. Whether 
this lack of effectiveness is due to drug-induced perseveration, inflexibility, arousal or some 
other factor(s) remains to be determined.  
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